Documentation of Male Genitourinary Exam with Testicular Concern
Document the exam systematically by recording inspection findings (scrotal skin, testicular position, masses), palpation results (testicular size, consistency, masses, tenderness), transillumination if indicated, and specific measurements of any abnormalities, while ensuring you obtain and document serum tumor markers (AFP, hCG, LDH) before any intervention if malignancy is suspected.
Essential Documentation Components
Initial Assessment Elements
When documenting a male GU exam with testicular concern, your chart must capture specific findings rather than generic statements 1:
Physical Examination Documentation:
- Inspection findings: Note scrotal skin appearance, symmetry, testicular position (descended bilaterally vs. undescended), visible masses or swelling
- Palpation results: Document each testis separately with size estimation (normal adult 4-5 cm length), consistency (firm, soft, hard), presence/absence of masses with specific location and size in centimeters
- Mass characteristics if present: Exact location, size measurements, consistency (solid vs. cystic), tenderness, fixation to surrounding structures
- Epididymis and vas deferens: Note if normal or abnormal
- Transillumination results: Positive (suggests fluid-filled) or negative (suggests solid mass)
Critical Pre-Treatment Documentation
Before any definitive management, you must document:
Serum tumor markers drawn: Explicitly note that AFP, hCG, and LDH were obtained BEFORE orchiectomy or other treatment 1. This is a moderate recommendation based on Grade C evidence and is critical for staging and prognosis.
Counseling provided: Document discussion of hypogonadism and infertility risks 1
Sperm banking offered: Particularly important if contralateral testis is abnormal or patient has known subfertility 1
Diagnostic Pathway Documentation
When Malignancy is Suspected
A solid mass on physical exam or imaging must be managed as malignant until proven otherwise 1. Your documentation should reflect this clinical principle:
- Order and document scrotal ultrasound with Doppler for any unilateral or bilateral scrotal mass suspicious for neoplasm 1
- Do NOT order MRI as initial evaluation—this is explicitly not recommended 1
- Any hypoechoic mass with vascular flow on ultrasound is highly suggestive of malignancy
For Indeterminate Findings
If exam and ultrasound are indeterminate with normal tumor markers, document:
- Plan for repeat imaging in 6-8 weeks 1
- Patient counseling about follow-up timing
- Red flag symptoms warranting earlier return
Common Documentation Pitfalls
Avoid these errors:
Generic templates without specific findings: Studies show over 99% of pediatric GU exams are "documented," but this may reflect EMR templates rather than actual thorough examination 2. Be specific about what you actually found.
Missing pre-treatment tumor markers: Drawing markers after orchiectomy eliminates critical staging information 1
Inadequate mass characterization: Document exact size, location, and consistency—not just "mass present"
Failing to document informed consent: The intimate nature of this exam requires explicit documentation of patient consent and chaperone presence 3
Structured Documentation Template
Use this framework:
GU EXAM - TESTICULAR CONCERN:
Chief Concern: [patient's specific complaint]
Inspection: Scrotal skin [normal/abnormal], symmetry [symmetric/asymmetric],
testicular position [bilateral descended/other]
Palpation:
- Right testis: [size in cm], [consistency], [masses: yes/no with details]
- Left testis: [size in cm], [consistency], [masses: yes/no with details]
- Epididymis: [normal bilaterally/abnormal with details]
- Spermatic cord: [normal/abnormal]
Transillumination: [positive/negative/not performed]
Labs ordered: AFP, hCG, LDH drawn [date/time] BEFORE intervention
Imaging ordered: Scrotal ultrasound with Doppler
Counseling provided: Discussed [hypogonadism/infertility risks/sperm banking]
Chaperone present: [name/role]This systematic approach ensures medicolegal protection, appropriate clinical management, and captures all elements necessary for staging if malignancy is confirmed 1.